田志刚，中科大，合肥——HBV相关实验室及人物介绍系列

田志刚，中国科技大学，合肥
乙肝天然免疫

Tian, Z. F. and Z. L. You, et al. (2016). "Effect of entecavir on CD4+ T-cell subpopulations in patients with chronic hepatitis B." Ann Hepatol 15(2): 174-82.
Yang, Y. and B. Zheng, et al. (2016). "Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinoma." Cancer Biol Ther 17(4): 449-56.
Chen, Y. and R. Sun, et al. (2016). "CD4+CD25+ Regulatory T Cells Inhibit Natural Killer Cell Hepatocytotoxicity of Hepatitis B Virus Transgenic Mice via Membrane-Bound TGF-beta and OX40." J Innate Immun 8(1): 30-42.
Li, M. and R. Sun, et al. (2015). "Kupffer Cells Support Hepatitis B Virus-Mediated CD8+ T Cell Exhaustion via Hepatitis B Core Antigen-TLR2 Interactions in Mice." J Immunol 195(7): 3100-9.
Yang, Z. and T. Tang, et al. (2015). "Type 1 innate lymphoid cells contribute to the pathogenesis of chronic hepatitis  B." Innate Immun 21(6): 665-73.
Kong, X. and R. Sun, et al. (2014). "gammadeltaT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance." J Immunol 193(4): 1645-53.
Xie, Y. and Q. Yao, et al. (2014). "Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma." Cancer Biol Ther 15(9): 1248-55.
Bi, J. and Q. Zhang, et al. (2014). "T-cell Ig and ITIM domain regulates natural killer cell activation in murine acute viral hepatitis." Hepatology 59(5): 1715-25.
Chen, Y. and H. Peng, et al. (2014). "CD49a promotes T-cell-mediated hepatitis by driving T helper 1 cytokine and interleukin-17 production." Immunology 141(3): 388-400.
Tian, Y. and D. Ni, et al. (2014). "Telbivudine treatment corrects HBV-induced epigenetic alterations in liver cells  of patients with chronic hepatitis B." Carcinogenesis 35(1): 53-61.
Xu, L. and W. Yin, et al. (2014). "Kupffer cell-derived IL-10 plays a key role in maintaining humoral immune tolerance in hepatitis B virus-persistent mice." Hepatology 59(2): 443-52.
Lv, S. and J. Wang, et al. (2014). "Nanoparticles encapsulating hepatitis B virus cytosine-phosphate-guanosine induce therapeutic immunity against HBV infection." Hepatology 59(2): 385-94.
Wang, Q. and J. Zhou, et al. (2013). "Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis." PLoS Pathog 9(6): e1003410.
Lan, P. and C. Zhang, et al. (2013). "Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance." Hepatology 58(1): 73-85.
Li, F. and H. Wei, et al. (2013). "Blocking the natural killer cell inhibitory receptor NKG2A increases activity of  human natural killer cells and clears hepatitis B virus infection in mice." Gastroenterology 144(2): 392-401.
Wang, X. and R. Sun, et al. (2013). "High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of gammadelta T cells with macrophages." Hepatology 57(1): 373-84.
Huang, M. and R. Sun, et al. (2013). "Simultaneous knockdown of multiple ligands of innate receptor NKG2D prevents natural killer cell-mediated fulminant hepatitis in mice." Hepatology 57(1): 277-88.
Li, Y. and G. Cao, et al. (2013). "CRACC-CRACC interaction between Kupffer and NK cells contributes to poly I:C/D-GalN induced hepatitis." PLoS One 8(9): e76681.
Zeng, Z. and X. Kong, et al. (2013). "IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier." J Immunol 191(8): 4184-93.
Han, Q. and P. Lan, et al. (2013). "Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation." J Gastroenterol Hepatol 28 Suppl 1: 132-7.
Lv, J. and Q. Jin, et al. (2012). "Antiviral treatment alters the frequency of activating and inhibitory receptor-expressing natural killer cells in chronic hepatitis B virus infected patients." Mediators Inflamm 2012: 804043.
Yin, W. and L. Xu, et al. (2012). "Interleukin-15 suppresses hepatitis B virus replication via IFN-beta production in a C57BL/6 mouse model." Liver Int 32(8): 1306-14.
Zhao, N. and J. Hao, et al. (2011). "Vgamma4 gammadelta T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis." J Immunol 187(10): 5007-14.
Han, Q. and C. Zhang, et al. (2011). "Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner." Hepatology 54(4): 1179-89.
Zhang, Z. and S. Zhang, et al. (2011). "Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients." Hepatology 53(1): 73-85.
Jin, Z. and R. Sun, et al. (2011). "Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells." Hepatology 53(1): 219-29.
Zhang, X. and H. X. Wei, et al. (2010). "Opposite effects of high and low doses of interleukin-2 on T cell-mediated hepatitis in mice (interleukin-2 on hepatitis)." Hepatol Int 4(3): 641-8.
Jiang, W. and R. Sun, et al. (2009). "TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells." J Immunol 182(6): 3768-74.
Hou, X. and R. Zhou, et al. (2009). "NKG2D-retinoic acid early inducible-1 recognition between natural killer cells and Kupffer cells in a novel murine natural killer cell-dependent fulminant hepatitis." Hepatology 49(3): 940-9.
Tian, Z. F. and H. Shen, et al. (2009). "Interaction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81." World J Gastroenterol 15(2): 240-4.
Wei, H. X. and Y. H. Chuang, et al. (2008). "CD4+ CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-beta-dependent manner in mice." J Immunol 181(10): 7221-9.
Feng, C. and H. Wang, et al. (2007). "Diammonium glycyrrhizinate, a component of traditional Chinese medicine Gan-Cao,  prevents murine T-cell-mediated fulminant hepatitis in IL-10- and IL-6-dependent  manners." Int Immunopharmacol 7(10): 1292-8.
Zhang, C. Z. and Z. X. Tian, et al. (2007). "[Virological, serological and clinical characteristics of anti-HBc IgM positive chronic hepatitis B patients]." Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 21(2): 138-40.
Chen, Y. and H. Wei, et al. (2007). "Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells." Hepatology 46(3): 706-15.
Chen, Y. and M. Cheng, et al. (2006). "Hepatitis B virus down-regulates expressions of MHC class I molecules on hepatoplastoma cell line." Cell Mol Immunol 3(5): 373-8.
Wang, J. and R. Sun, et al. (2006). "Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism." J Hepatol 44(3): 446-54.
Dong, Z. and C. Zhang, et al. (2005). "Impaired NK cell cytotoxicity by high level of interferon-gamma in concanavalin A-induced hepatitis." Can J Physiol Pharmacol 83(11): 1045-53.
Zhao, X. P. and Z. F. Tian, et al. (2005). "[Infection of tupaia hepatocytes with hepatitis C virus in vitro]." Zhonghua Gan Zang Bing Za Zhi 13(11): 805-7.
Chen, Y. and H. Wei, et al. (2005). "Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response." J Viral Hepat 12(1): 38-45.
Zhao, Y. L. and Y. G. Chen, et al. (2004). "[Safety and immunogenicity of Bilive combined hepatitis A and B vaccine]." Zhonghua Liu Xing Bing Xue Za Zhi 25(6): 470-3.
Sun, R. and Z. Tian, et al. (2004). "IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners." J Immunol 172(9): 5648-55.
Zhang, C. P. and Z. B. Tian, et al. (2004). "Effects of Zhaoyangwan on chronic hepatitis B and posthepatic cirrhosis." World J Gastroenterol 10(2): 295-8.
Zhang, Y. M. and M. Li, et al. (2003). "[Cloning and expression of hepatitis C core protein gene]." Di Yi Jun Yi Da Xue Xue Bao 23(10): 1018-20.
Hong, F. and B. Jaruga, et al. (2002). "Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS." J Clin Invest 110(10): 1503-13.